NCT02862483View on ClinicalTrials.gov

The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction

PHASE3UnknownINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Benign Prostatic HyperplasiaErectile Dysfunction
Interventions
DRUG

Tamsulosin 0.2mg

DRUG

Tadalafil 5mg

DRUG

Placebo for Tamsulosin

Trial Locations (1)

Unknown

RECRUITING

Catholic university of korea, Seoul ST. Mary's Hospital., Seoul

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT02862483 - The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction | Biotech Hunter | Biotech Hunter